Table 4. Hazard ratios in the vascular dementia and degenerative dementia groups.
Variables | Basic model | Full model | ||
---|---|---|---|---|
HR | 95% CI | HR | 95% CI | |
Age (increased 1 year) | 1.08 | 1.07–1.08 | 1.08 | 1.07–1.08 |
Male (ref: female) | 1.36 | 1.30–1.41 | 1.29 | 1.24–1.34 |
Vascular dementia (ref: non-dementia) | ||||
No medication | 2.90 | 2.62–3.21 | 2.46 | 2.22–2.72 |
Nootropics | 1.50 | 1.37–1.63 | 1.25 | 1.15–1.37 |
Degenerative dementia (ref: non-dementia) | ||||
No medication | 2.91 | 2.76–3.6 | 2.69 | 2.55–2.83 |
Nootropics | 1.61 | 1.53–1.70 | 1.46 | 1.39–1.54 |
Anti-dementia medication | 1.06 | 0.83–1.36 | 1.05 | 0.82–1.34 |
Both medications | 0.96 | 0.84–1.10 | 0.92 | 0.80–1.05 |
Socioeconomic status (ref: low) | ||||
Medium | 0.99 | 0.92–1.06 | ||
High | 0.98 | 0.92–1.04 | ||
Urbanity (ref: urban) | ||||
Suburban | 1.10 | 1.05–1.15 | ||
Rural | 1.19 | 1.13–1.27 | ||
Charlson comorbidity index (increased 1) | 1.14 | 1.13–1.14 |